Cited by 121Axon Guidance and Neuronal SignalingNeurogenesis and neuroplasticity mechanismsNeuroscience and Neuropharmacology Research

Functional Dissection of Reelin Signaling by Site-Directed Disruption of Disabled-1 Adaptor Binding to Apolipoprotein E Receptor 2: Distinct Roles in Development and Synaptic Plasticity

Open access
Beffert, Uwe, Durudas, Andre, Weeber, Edwin J., Stolt, Peggy C., Giehl, Klaus M., Sweatt, J. David, Hammer, Robert E., Herz, Joachim·2006·The Journal of Neuroscience

Abstract

The Reelin signaling pathway controls neuronal positioning in human and mouse brain during development as well as modulation of long-term potentiation (LTP) and behavior in the adult. Reelin signals by binding to two transmembrane receptors, apolipoprotein E receptor 2 (Apoer2) and very-low-density lipoprotein receptor. After Reelin binds to the receptors, Disabled-1 (Dab1), an intracellular adaptor protein that binds to the cytoplasmic tails of the receptors, becomes phosphorylated on tyrosine residues, initiating a signaling cascade that includes activation of Src-family kinases and Akt. Here, we have created a line of mutant mice (Apoer2 EIG) in which the Apoer2 NFDNPVY motif has been altered to EIGNPVY to disrupt the Apoer2–Dab1 interaction to further study Reelin signaling in development and adult brain. Using primary neuronal cultures stimulated with recombinant Reelin, we find that normal Reelin signaling requires the wild-type NFDNPVY sequence and likely the interaction of Apoer2 with Dab1. Furthermore, examination of hippocampal, cortical, and cerebellar layering reveals that the NFDNPVY sequence of Apoer2 is indispensable for normal neuronal positioning during development of the brain. Adult Apoer2 EIG mice display severe abnormalities in LTP and behavior that are distinct from those observed for mice lacking Apoer2. In Apoer2 EIG slices, LTP degraded to baseline within 30 min, and this was prevented in the presence of Reelin. Together, these findings emphasize the complexity of Reelin signaling in the adult brain, which likely requires multiple adaptor protein interactions with the intracellular domain of Apoer2.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.4566-05.2006

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Replacing three residues upstream of the NPVY motif is sufficient to prevent DAB1 from binding APOER2 both in vitro and in vivo.

    “This is in good agreement with Beffert et al. (34) who demonstrated that replacing three residues upstream of the NPVY motif is sufficient to prevent DAB1 from binding APOER2 both in vitro and in vivo.”

    From Distinct Functional Domains Contribute to Degradation of the Low Density Lipoprotein Receptor (LDLR) by the E3 Ubiquitin Ligase Inducible Degrader of the LDLR (IDOL) (2011) · cites this paper as [34]

    In “Generation and characterization of Apoer2-Dab1 binding site mutant mice” (page unavailable), the paper identifies the three substitutions and reports that mutant Apoer2 did not bind Dab1 in an in vitro pull-down assay. The Discussion (page unavailable) says examination of the mutant mice *implies* that the functional interaction was disrupted; it does not demonstrate that Dab1 binding was prevented in vivo. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • ApoER2 contains a multifunctional NPxY motif responsible for its signaling, endocytosis, and interaction with several adaptor proteins.

    “Similar to other members of the LDL-R family, ApoER2 contains a multifunctional NPxY motif, which is responsible for its signaling [4], [11], endocytosis [24] and also the role of facilitating the interaction with several adaptor proteins [54], [55].”

    From Sorting nexin 17 regulates ApoER2 recycling and reelin signaling (2014) · cites this paper as [11]

    The Discussion identifies the ApoER2 NPXY motif as necessary for Dab1 binding and Reelin signaling, and the endocytosis section reports internalization by receptors bearing ApoER2 intracellular domains. But the Discussion places binding of the other named adaptor proteins, JIP1/2 and PSD95, at exon 19 rather than the NPXY motif; it only suggests that other proteins may also bind that motif. The paper also says endocytosis is unlikely to be a major biological function of ApoER2. Page numbers are unavailable in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Beffert, U., Durudas, A., Weeber, E. J., Stolt, P. C., Giehl, K. M., Sweatt, J. D., Hammer, R. E., & Herz, J.
Affiliations
  • The University of Texas Southwestern Medical Center (US)
  • Vanderbilt University (US)
  • The University of Texas at Dallas (US)
  • Baylor College of Medicine (US)
Venue
The Journal of Neuroscience
Published
2006-02-15
Volume
26
Issue
7
Pages
2041-2052
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2003017196
Cited by
121
References
3
Citations by year
2026: 3 · 2025: 4 · 2024: 3 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 1 · 2019: 1 · 2018: 4 · 2017: 6 · 2016: 9 · 2015: 9 · 2014: 6 · 2013: 7 · 2012: 6
FWCI
3.94
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Alzheimer's Association
  • Alexander von Humboldt-Stiftung
  • National Institutes of Health (HL20948, HL63762)
  • National Heart, Lung, and Blood Institute (HL-20948, HL63762, R37HL063762, P01HL020948)
  • National Institute of Mental Health (MH 57014, R01MH057014)
  • National Institute of Neurological Disorders and Stroke (NS-13546, NS43408, R01NS013546, R01NS043408)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Axon Guidance and Neuronal Signaling
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
Reelin signaling, ApoER2, Disabled-1, neuronal positioning, brain development, synaptic plasticity, long-term potentiation, hippocampus, Src family kinases, Akt signaling, mouse mutants
MeSH terms
Reelin Protein, Animals, Cricetinae, Humans, Nerve Tissue Proteins, Serine Endopeptidases, Signal Transduction, Cell Adhesion Molecules, Neuronal, Mutagenesis, Site-Directed, Extracellular Matrix Proteins, CHO Cells, Receptors, Lipoprotein, LDL-Receptor Related Proteins, Adaptor Proteins, Signal Transducing, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review